Gene Editing: A New Tool for Viral Disease

Area of Science:

• Microbiology
• Genetics
• Virology

Background:

• The CRISPR/Cas system, originally discovered as bacterial antiviral immunity, is now a powerful gene-editing tool.
• Gene editing holds promise for treating human diseases, particularly those stemming from germline mutations.
• DNA viruses causing chronic diseases remain a challenge for current therapeutics.

Purpose of the Study:

• To review the current applications of gene editing for treating diseases caused by DNA viruses.
• To discuss the potential benefits and challenges of using gene editing as a therapeutic strategy against DNA virus-induced pathologies.

Main Methods:

• Review of current scientific literature on CRISPR/Cas gene editing.
• Analysis of studies focusing on gene editing applications for viral diseases.
• Discussion of the advantages and limitations of gene editing therapies.

Main Results:

• CRISPR/Cas gene editing is a facile system adaptable for mammalian cells.
• Gene editing presents a potential novel treatment for germline mutations and chronic DNA virus infections.
• The field is rapidly advancing, with ongoing research into therapeutic applications.

Conclusions:

• Gene editing, particularly CRISPR/Cas, shows significant potential as a therapeutic modality for DNA virus-related diseases.
• Further research is needed to overcome challenges and fully realize the therapeutic potential of gene editing.
• This technology could revolutionize the treatment of chronic viral infections and genetic disorders.